Vimarsana
Biggest News Aggregation in the World

Combined Current News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Combined Current. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Combined Current Today - Breaking & Trending Today

Investegate |Amarin Corporation plc Announcements | Amarin Corporation plc: New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent ethyl) Reduced Cardiovascular Events in Patients Who Are Current or Former Smokers - Vimarsana News

Investegate |Amarin Corporation plc Announcements | Amarin Corporation plc: New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent ethyl) Reduced Cardiovascular Events in Patients Who Are Current or Former Smokers

Published: August 28, 2022

Investegate announcements from Amarin Corporation plc, New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent ethyl) Reduced Cardiovascular Events in Patients Who Are Current or Former Smokers

Source: investegate.co.uk
Related Topics:
United StatesNew JerseyUniversity Of PennsylvaniaComunidad Autonoma De CatalunaMichael MillerAmarin CorporationEuropean Society Of CardiologyJournal Of The American College CardiologyHospital Of The University PennsylvaniaOral Abstract At European Society Of CardiologyData ShowReduced Cardiovascular EventsPatients Who Are CurrentReduced FirstTotal Cardiovascular EventsCombined CurrentFormer SmokersRespectively RelativePost HocOral AbstractEuropean SocietyVice ChairNew England JournalAmerican CollegeInvestegate Announcements
Amarin Corporation plc: New REDUCE-IT Data Show VASCEPA/VAZKEPA (icosapent ethyl) Reduced Cardiovascular Events in Patients Who Are Current or Former Smokers - Vimarsana News

Amarin Corporation plc: New REDUCE-IT Data Show VASCEPA/VAZKEPA (icosapent ethyl) Reduced Cardiovascular Events in Patients Who Are Current or Former Smokers

Published: August 28, 2022

-- Data Show VASCEPA/VAZKEPA Significantly Reduced First and Total Cardiovascular Events in Combined Current and Former Smokers by 23% and 29% Respectively Relative to Placebo in a Post Hoc Analysis

Source: finanznachrichten.de
Related Topics:
United StatesNew JerseyUnited KingdomUniversity Of PennsylvaniaUnited Arab EmiratesComunidad Autonoma De CatalunaGreat BritainClin CardiolColl CardiolMichael MillerJ Cardiovasc PharmacotherAmerican Heart AssociationOral Abstract At European Society Of CardiologyDrug AdministrationExchange CommissionAmarin CorporationEuropean UnionEuropean Society Of CardiologyAmarin Pharmaceuticals IrelandJournal Of The American College CardiologyHospital Of The University PennsylvaniaA Report From The American Heart AssociationReduced FirstTotal Cardiovascular EventsCombined Current